Two major contributors to reduced health-related quality of life (HRQoL) in patients with chronic lymphocytic leukemia (CLL) and lymphoma are muscle weakness and fatigue, according to a study ...

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and ...

Statin therapy potentially reduces cancer mortality risk by 60%, a new study indicates. LONDON, April 24: ...

Studies have shown that using statin drugs used to treat hyperlipidemia as a combination therapy can reduce the risk of ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

Scientists in the UAE, who tracked over 1,000 patients with the disease, found those on the drug were almost two thirds less ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who were taking cholesterol-lowering ...

Statins work by reducing the amount of “bad” LDL cholesterol made by the liver and helping it to remove cholesterol from the ...

Researchers discovered that patients who took a statin had a 61 per cent reduced risk of dying from their cancer ...